In this week’s episode, Meri shares his journey from the world of investing to breaking the bottlenecks in clinical trials as he builds the anti-CRO for life science pioneers.  We discussed:  🔄 Transitioning from venture capital into healthtech 💼 Investor vs Founder Traits, Personality and Mindset🌱 The origin story of Lindus Health 🏗️ The first few days/weeks of building Lindus Health 🚧 Barriers to entering the pharma industry as a new startup🔒 Securing the first clinical trial with Habitual🍾 The bottle necks of clinical trials🔍 The process of recruiting patients for clinical trials❌ Where central organisations and institutions go wrong for clinical trials🤖 The role of AI in the pharma industry 💰 Fundraising a $18m Series A with investments from the likes of Peter Thiel 🔒 How to prevent being replaced by the board and investors 🏢 How to build a healthy culture and team 🤝 How to become a great CEO and deal with co-founder conflicts💊 Why do pharma need CROs for clinical trials and why become the anti-CRO Meri Beckwith is the co-founder of Lindus Health and previously a venture capital investor and partner to biotech and digital health companies. He took part in the COVID-19 vaccine trials as a volunteer, where he saw trail outcomes could be improved by focusing on patient experience.    ------------------------------------- Powered by  Peerr Peerr is a healthtech platform connecting the health and life sciences industry through content and thought leaders, KOLs and SMEs. ✍️ Publish articles or blogs, courses or offer coaching services 🗒 Over 250,000+ reads and 500+ articles   www.peerr.io -------------------------------------   YouTube:Amz & Abdul Twitter -@ScrubbedIn_Instagram - @Scrubbedin_ Follow us on Instagram & Twitter Hello@scrubbedin.co.uk